Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.002x

Based on the latest financial reports, Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) has a cash flow conversion efficiency ratio of -0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL-3.02 Million ≈ $-67.59K USD) by net assets (TL1.68 Billion ≈ $37.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Anatolia Tani ve Biyoteknoloji Urunleri (ANGEN) market capitalisation for the company's overall valuation and market capitalisation.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret ranked by their cash flow conversion efficiency. Explore Anatolia Tani ve Biyoteknoloji Urunleri (ANGEN) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Euroholdings Ltd.
NASDAQ:EHLD
0.215x
Zenith Minerals Ltd
AU:ZNC
-0.028x
MS Industrie AG
F:MSAG
0.082x
Wesizwe
JSE:WEZ
-0.080x
Summa Silver Corp
V:SSVR
-0.009x
Mirae Asset Global REIT Co. Ltd.
KO:396690
-0.005x
Crest Group Berhad
KLSE:0323
-0.030x
Apexindo Pratama Duta Tbk
JK:APEX
0.129x

Annual Cash Flow Conversion Efficiency for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (2018–2024)

The table below shows the annual cash flow conversion efficiency of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret from 2018 to 2024. View current stock price of Anatolia Tani ve Biyoteknoloji Urunleri for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 TL1.55 Billion
≈ $34.75 Million
TL141.41 Million
≈ $3.17 Million
0.091x -62.37%
2023-12-31 TL1.75 Billion
≈ $39.23 Million
TL424.36 Million
≈ $9.50 Million
0.242x -36.41%
2022-12-31 TL816.40 Million
≈ $18.29 Million
TL311.02 Million
≈ $6.97 Million
0.381x -22.74%
2021-12-31 TL825.79 Million
≈ $18.50 Million
TL407.20 Million
≈ $9.12 Million
0.493x -29.63%
2020-12-31 TL336.01 Million
≈ $7.53 Million
TL235.47 Million
≈ $5.27 Million
0.701x +81.53%
2019-12-31 TL17.32 Million
≈ $387.97K
TL6.69 Million
≈ $149.77K
0.386x +16.46%
2018-12-31 TL9.53 Million
≈ $213.55K
TL3.16 Million
≈ $70.79K
0.331x --

About Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

IS:ANGEN Turkey Medical Devices
Market Cap
$38.04 Million
TL1.70 Billion TRY
Market Cap Rank
#23027 Global
#368 in Turkey
Share Price
TL7.72
Change (1 day)
-4.34%
52-Week Range
TL7.72 - TL14.70
All Time High
TL23.13
About

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid ext… Read more